Nipro

Basic Information

Stock Code
8086
Industry
Precision Instruments
Category Detail
Biotechnology & Pharmaceuticals
Prefecture
Osaka Prefecture
Establishment Year
July 1954
Listing Year
February 1987
Official Website
https://www.nipro.co.jp/
TSE Information
TSE Information
Yahoo! Finance
Yahoo! Finance
Other Companies
Hogy Medical, Tsumura, Terumo, Sawai Group Holdings, Create Medic, Nihon Kohden, Sysmex, Ushio, JMS, Manny, Asahi Intecc, Medikit, Taikenchiku, Menicon, Shofu, Nifco

Overview

Nipro is a leading company in the precision instruments industry, a major manufacturer of medical devices, pharmaceuticals, and glass products founded in 1954, with particular strengths in the dialysis equipment sector.

Current Situation

For the fiscal year ending March 2025, Nipro achieved consolidated sales of approximately 644.5 billion yen and operating profit of 26.5 billion yen. It maintains high market shares domestically and internationally in dialyzers and medical supplies & disposables, while focusing on generic drugs and contract manufacturing. The company operates numerous subsidiaries worldwide and handles a diverse range of medical-related products. In recent years, it has expanded growth opportunities through partnerships with Korean companies in biosimilars and expansion in endoscopy-related businesses. As part of addressing social challenges, it emphasizes improving the quality and safety of medical care, striving to enhance the quality of pharmaceuticals and medical devices. It also aims for sustainable management by actively promoting environmental burden reduction and community contribution activities. Moving forward, it will promote product development leveraging advanced technologies and new business expansion, accelerating its growth strategy toward 2030.

Trivia

Interesting Facts

  • Established in July 1954 as a sales company for medical glass tubes.
  • Boasts top-class domestic market share in dialysis equipment.
  • Received Good Design Award in 2005.
  • Multinational enterprise with numerous domestic and international subsidiaries and affiliates.
  • Known as a sponsor of TV programs.
  • Actively advancing into biosimilars in recent years.
  • New headquarters relocated to Kita-Osaka Healthy Medical City in 2023.
  • Highly evaluated for manufacturing technology of diverse medical glass products.
  • Entering medical IT market through medical software development.
  • Current trade name resulted from merger with dormant company.

Hidden Connections

  • Strong capital ties with Nippon Electric Glass, deep collaboration in medical glass products.
  • Accelerating global expansion in pharmaceutical packaging through overseas subsidiaries.
  • In 2012, strengthened business foundation through merger of two generations of Nihon Glass Shoji.
  • Many generic drug products are co-sold with major pharmaceutical companies.
  • Former president Minoru Sano also served as president of the Osaka Prefectural Association in Yamanashi.
  • Subsidiaries in the US, Europe, and Asian countries in medical devices.
  • In addition to medical devices, develops and sells medical software.
  • Repeated capital investments and transfers in the drugstore sector in the past.

Future Outlook

Growth Drivers

  • Demand expansion from increasing dialysis patients due to aging population
  • Expansion of generic drug market and healthcare cost containment needs
  • Entry into emerging markets through global expansion
  • Advancement of medical devices using AI and IoT technologies
  • Market expansion from technological innovations in endoscopes and diagnostics
  • Increasing demand for medical IT solutions
  • Strengthened social demand for sustainable medical products
  • Enhanced customer trust through product safety and quality improvements
  • New business opportunities from genericization of pharmaceuticals
  • Increasing market needs for medical devices to counter emerging infectious diseases
  • Expansion of technology and markets through overseas partnerships and M&A
  • Enhancement of services for healthcare professionals

Strategic Goals

  • Achieve 40% global market share in dialysis products
  • Realize over 100 billion yen in sales from generic drugs
  • Enter top 5 in Asian biosimilar market
  • Establish manufacturing processes with significant environmental burden reduction
  • Expand medical IT business revenue share to over 20%
  • Secure annual R&D investment at 5% of sales for new product development
  • Obtain international certifications for quality and safety on all products
  • Promote recruitment and active roles for diverse talent
  • Expand social contribution activities in regional healthcare and welfare
  • Improve operational efficiency by 30% compared to 2025 through DX initiatives

Business Segments

Artificial Dialysis Equipment Business

Overview
Supplies artificial dialysis equipment and consumables domestically and internationally, holding high market share.
Competitiveness
Technology honed in dialysis specialization and extensive sales network
Customers
  • Hospitals
  • Dialysis Clinics
  • Medical Device Leasing Companies
  • Medical Equipment Wholesalers
  • Overseas Medical Institutions
Products
  • Hemodialysis Machines
  • Dialysis Circuit Sets
  • Dialysate
  • Peritoneal Dialysis Products
  • Dialysis Consumables

Medical Supplies & Disposables Business

Overview
Develops and supplies diverse medical consumables to medical institutions domestically and internationally.
Competitiveness
Stable supply system for high-quality medical supplies
Customers
  • Hospitals
  • Pharmacies
  • Home Nursing Stations
  • Clinics
  • Medical Device Retailers
Products
  • Syringes
  • Catheters
  • Infusion Sets
  • Medical Glass Containers
  • Medical Disinfectants

Medical Devices Business

Overview
Develops and sells advanced medical devices to support diagnosis and treatment in medical institutions.
Competitiveness
Product development closely tied to medical sites
Customers
  • General Hospitals
  • Specialty Clinics
  • Medical Device Sales Agents
  • Clinics
  • Overseas Medical Institutions
Products
  • Endoscope Devices
  • ECGs
  • Ultrasound Devices
  • Infusion Pumps
  • Blood Flow Meters

Generic Drugs Business

Overview
Manufactures and sells a wide variety of generic drugs contributing to healthcare cost reduction.
Competitiveness
R&D capabilities and diverse product lineup
Customers
  • Hospitals
  • Pharmacies
  • Pharmaceutical Wholesalers
  • Generic Drug Sales Companies
Products
  • Generic Tablets
  • Oral Anticoagulants
  • Transdermal Patches
  • Injectable Biosimilars

Pharmaceutical Packaging & Glass Products Business

Overview
Stably supplies pharmaceutical glass containers and packaging materials.
Competitiveness
High-precision, multi-variety production technology
Customers
  • Pharmaceutical Manufacturers
  • Biopharmaceutical Companies
  • Medical Device Manufacturers
  • Packaging Material Manufacturers
Products
  • Injection Glass Ampoules
  • Glass Tubes for Tablet Bottles
  • Vials
  • PTP Packaging Materials

Medical IT & Solutions Business

Overview
Provides software to support operational efficiency in medical institutions.
Competitiveness
Product development tailored to medical site needs
Customers
  • Hospitals
  • Pharmacies
  • Medical Device Sales Companies
  • Medical Institution IT Staff
Products
  • Electronic Medical Records Integration System
  • Drug Management Software
  • Remote Consultation Platform

Competitive Advantage

Strengths

  • Industry-leading market share in medical dialysis equipment
  • In-house integrated production of diverse medical supplies
  • Global sales and production network
  • Advanced R&D structure and technological capabilities
  • Hybrid business model of pharmaceuticals and medical devices
  • Strong brand power and customer trust
  • Rich lineup of medical glass products
  • Market expansion via multinational subsidiaries
  • Long-established relationships in the medical industry
  • Excellent quality management system

Competitive Advantages

  • Overwhelming market share and technological superiority in dialysis products
  • Addresses healthcare cost reduction needs through generic drug manufacturing and sales
  • Advanced production technology in medical glass products
  • Covers market needs with diverse medical device lineup
  • Extensive domestic and international sales subsidiaries and strong sales channels
  • Advances product differentiation through high R&D investment
  • Develops new revenue sources by entering medical IT
  • Enhances customer loyalty through safety and quality assurance
  • Secures stable revenue base with multiple businesses
  • Diversifies business through international partnerships and acquisitions

Threats

  • Stricter regulations on medical devices
  • Risk of declining competitiveness due to delayed technological innovation
  • Revenue instability from exchange rate fluctuations
  • Intensified competition from new entrants
  • Brand damage from product recalls or quality issues
  • Political and economic fluctuations in global medical markets
  • Revenue decline from patent expirations
  • Pressure to lower pharmaceutical prices
  • Market contraction risk from emerging infectious diseases
  • Intensified competition for highly skilled talent

Innovations

2024: Partnership with Korean company in biosimilars

Overview
Formed strategic partnership with Korean company for biosimilar development.
Impact
Strengthens competitiveness in pharmaceutical business through product lineup expansion

2023: Development and subsidiary acquisition of new endoscopy products

Overview
Acquired endoscopy manufacturing and sales company as subsidiary to expand business.
Impact
Qualitative enhancement of medical devices business and acquisition of new markets

2022: Improved functionality of safe injection needles

Overview
Developed new safety-enhanced injection needle design to prevent foreign matter contamination.
Impact
Contributes to elevating safety management standards in medical settings

2021: Release of electronic medical records integration software

Overview
Launched user-friendly medical IT solutions.
Impact
Supports operational efficiency in medical institutions

2020: Launch of energy-saving new dialysis equipment model

Overview
Developed and launched energy-saving dialysis equipment contributing to environmental burden reduction.
Impact
Improves customer satisfaction and market competitiveness

Sustainability

  • Promoting CO2 emission reduction programs in manufacturing processes
  • Promoting recycling of medical waste
  • Strengthening CSR activities through regional medical contributions and hospital collaborations
  • Adopting environmentally friendly pharmaceutical packaging materials
  • Promoting development of safe and sustainable medical devices
  • Advancing organizational culture that respects diversity and inclusion